Cipla's partners to move S African Constitutional Court in docetaxel case
This article was originally published in Scrip
Executive Summary
Cipla's partners in South Africa plan to approach the Constitutional Court there and challenge a recent judgement against them in a case concerning the Indian firm's generic version of Sanofi's anticancer Taxotere (docetaxel).